30 April 2025

RUA Life Sciences plc

("RUA Life Sciences", the "Company" or the "Group")

Change of registered office

RUA Life Sciences, the holding company of a group of medical device businesses focused on the exploitation of the world's leading long-term implantable biostable polymer (Elast-EonTM), confirms that it has changed its registered office and UK head office from 163 Bath Street, Glasgow G2 4SQ to 2 Drummond Crescent, Riverside Business Park, Irvine, Ayrshire, KA11 5AN with effect from 30 April 2025.

For further information contact:

RUA Life Sciences                                                                                                                                                                                         

Bill Brown, Chief Executive                                                                         Tel: +44 (0)1294 317073

Lachlan Smith, Group Chief Financial Officer

Cavendish Capital Markets Limited

(Nominated Adviser and Broker)                                                             Tel: +44 (0)20 7220 0500

Giles Balleny/Dan Hodkinson (Corporate Finance)                                  

Charlie Combe (Broking)

Nigel Birks (Healthcare Specialist Sales)

Michael Johnson (Sales)

About RUA Life Sciences

RUA Life Sciences plc is the ultimate parent company of the Group, whose principal activities comprise exploiting the value of its IP & know-how, medical device contract manufacturing and development of medical devices.